• 1
    Akdis M, Blaser K, Akdis CA. T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 2005;116: 961968.
  • 2
    Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arberg J et al. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004;363: 608615.
  • 3
    Wilson DR, Torres LI, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005;60: 412.
  • 4
    Fenoglio D, Puppo F, Cirillo I, Vizzaccaro A, Ferrera A, Tosca MA et al. Sublingual specific immunotherapy reduces PBMC proliferations. Allergol Immunol 2005;37: 147151.
  • 5
    Ciprandi G, Fenoglio D, Cirillo I, Vizzaccaro A, Ferrero A, Tosca MA et al. Sublingual HDM-specific immunotherapy induces IL-10 production: preliminary report. Ann Allergy Asthma Immunol 2005;95: 3844.
  • 6
    Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA, Massolo A, Passalacqua G. Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol 2005;136: 266272.